179 related articles for article (PubMed ID: 32908802)
1. Integrating Differential Gene Expression Analysis with Perturbagen-Response Signatures May Identify Novel Therapies for Thyroid-Associated Orbitopathy.
Lee JY; Gallo RA; Ledon PJ; Tao W; Tse DT; Pelaez D; Wester ST
Transl Vis Sci Technol; 2020 Aug; 9(9):39. PubMed ID: 32908802
[TBL] [Abstract][Full Text] [Related]
2. RNA-Sequencing Gene Expression Profiling of Orbital Adipose-Derived Stem Cell Population Implicate HOX Genes and WNT Signaling Dysregulation in the Pathogenesis of Thyroid-Associated Orbitopathy.
Tao W; Ayala-Haedo JA; Field MG; Pelaez D; Wester ST
Invest Ophthalmol Vis Sci; 2017 Dec; 58(14):6146-6158. PubMed ID: 29214313
[TBL] [Abstract][Full Text] [Related]
3. Transcriptomic Profiling of Control and Thyroid-Associated Orbitopathy (TAO) Orbital Fat and TAO Orbital Fibroblasts Undergoing Adipogenesis.
Kim DW; Taneja K; Hoang T; Santiago CP; McCulley TJ; Merbs SL; Mahoney NR; Blackshaw S; Rajaii F
Invest Ophthalmol Vis Sci; 2021 Jul; 62(9):24. PubMed ID: 34269815
[TBL] [Abstract][Full Text] [Related]
4. Clinical Management and Therapeutic Strategies for the Thyroid-Associated Ophthalmopathy: Current and Future Perspectives.
Mishra S; Maurya VK; Kumar S; Ankita ; Kaur A; Saxena SK
Curr Eye Res; 2020 Nov; 45(11):1325-1341. PubMed ID: 32567373
[TBL] [Abstract][Full Text] [Related]
5. Differentially expressed genes in orbital adipose/connective tissue of thyroid-associated orbitopathy.
Wang Y; Liu Y; Cai J; Zong T; Zhang Z; Xie T; Mu T; Wu M; Yang Q; Wang Y; Wang X; Yao Y
PeerJ; 2023; 11():e16569. PubMed ID: 38130930
[TBL] [Abstract][Full Text] [Related]
6. The Effect of Prostaglandin Analogue Bimatoprost on Thyroid-Associated Orbitopathy.
Choi CJ; Tao W; Doddapaneni R; Acosta-Torres Z; Blessing NW; Lee BW; Pelaez D; Wester ST
Invest Ophthalmol Vis Sci; 2018 Dec; 59(15):5912-5923. PubMed ID: 30551199
[TBL] [Abstract][Full Text] [Related]
7. TGFβ-Treated Placenta-Derived Mesenchymal Stem Cells Selectively Promote Anti-Adipogenesis in Thyroid-Associated Ophthalmopathy.
Shin HA; Park M; Banga JP; Lew H
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628410
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor 1 promotes the proliferation and adipogenesis of orbital adipose-derived stromal cells in thyroid-associated ophthalmopathy.
Zhao P; Deng Y; Gu P; Wang Y; Zhou H; Hu Y; Chen P; Fan X
Exp Eye Res; 2013 Feb; 107():65-73. PubMed ID: 23219871
[TBL] [Abstract][Full Text] [Related]
9. Depot-specific characteristics of adipose tissue-derived stromal cells in thyroid-associated orbitopathy.
Wong JSC; Chu WK; Li BF; Pang CP; Chong KK
Br J Ophthalmol; 2018 Aug; 102(8):1173-1178. PubMed ID: 29666119
[TBL] [Abstract][Full Text] [Related]
10. Incorporating Differential Gene Expression Analysis with Predictive Biomarkers to Identify Novel Therapeutic Drugs for Fuchs Endothelial Corneal Dystrophy.
Wen H; Gallo RA; Huang X; Cai J; Mei S; Farooqi AA; Zhao J; Tao W
J Ophthalmol; 2021; 2021():5580595. PubMed ID: 34258047
[TBL] [Abstract][Full Text] [Related]
11. Elevated bone morphogenic protein 4 expression implicated in site-specific adipogenesis in thyroid associated orbitopathy.
Wong JSC; Chu WK; Li BFL; Zhang BN; Pang CP; Chong KKL
Exp Eye Res; 2019 Apr; 181():185-189. PubMed ID: 30721670
[TBL] [Abstract][Full Text] [Related]
12. Biguanides Metformin and Phenformin Generate Therapeutic Effects via AMP-Activated Protein Kinase/Extracellular-Regulated Kinase Pathways in an In Vitro Model of Graves' Orbitopathy.
Han YE; Hwang S; Kim JH; Byun JW; Yoon JS; Lee EJ
Thyroid; 2018 Apr; 28(4):528-536. PubMed ID: 29589999
[TBL] [Abstract][Full Text] [Related]
13. The role of 11beta-hydroxysteroid dehydrogenase 1 in adipogenesis in thyroid-associated ophthalmopathy.
Tomlinson JW; Durrani OM; Bujalska IJ; Gathercole LL; Tomlins PJ; Reuser TT; Rose GE; Curnow SJ; Stewart PM; Walker EA; Rauz S
J Clin Endocrinol Metab; 2010 Jan; 95(1):398-406. PubMed ID: 19880789
[TBL] [Abstract][Full Text] [Related]
14. L1000CDS
Duan Q; Reid SP; Clark NR; Wang Z; Fernandez NF; Rouillard AD; Readhead B; Tritsch SR; Hodos R; Hafner M; Niepel M; Sorger PK; Dudley JT; Bavari S; Panchal RG; Ma'ayan A
NPJ Syst Biol Appl; 2016; 2():16015-. PubMed ID: 28413689
[TBL] [Abstract][Full Text] [Related]
15. 4-Methylumbelliferone suppresses hyaluronan and adipogenesis in primary cultured orbital fibroblasts from Graves' orbitopathy.
Yoon Y; Chae MK; Lee EJ; Yoon JS
Graefes Arch Clin Exp Ophthalmol; 2020 May; 258(5):1095-1102. PubMed ID: 31900640
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory Effect of Idelalisib, a Selective Phosphatidylinositol 3-Kinase δ Inhibitor, on Adipogenesis in an In Vitro Model of Graves' Orbitopathy.
Ko J; Kim JY; Lee EJ; Yoon JS
Invest Ophthalmol Vis Sci; 2018 Sep; 59(11):4477-4485. PubMed ID: 30193323
[TBL] [Abstract][Full Text] [Related]
17. Machine learning-based prediction of diagnostic markers for Graves' orbitopathy.
Cai Y; Su H; Si Y; Ni N
Endocrine; 2023 Aug; 81(2):277-289. PubMed ID: 37059863
[TBL] [Abstract][Full Text] [Related]
18. [Effects of LPS-induced inflammation on differentiation of orbital pre-adipocytes in thyroid-associated ophthalmopathy].
Yi WS; Xu XL
Zhonghua Yan Ke Za Zhi; 2011 Feb; 47(2):156-61. PubMed ID: 21426847
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling of orbital adipose tissue from patients with Graves' ophthalmopathy: a potential role for secreted frizzled-related protein-1 in orbital adipogenesis.
Kumar S; Leontovich A; Coenen MJ; Bahn RS
J Clin Endocrinol Metab; 2005 Aug; 90(8):4730-5. PubMed ID: 15886250
[TBL] [Abstract][Full Text] [Related]
20. Effect of tanshinone IIA in an in vitro model of Graves' orbitopathy.
Rhiu S; Chae MK; Lee EJ; Lee JB; Yoon JS
Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):5900-10. PubMed ID: 25159204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
